Form 4: Rhythm Pharmaceuticals CFO Hunter C. Smith Sells Shares to Cover Tax Obligations
SEC Form 4
Hunter C. Smith, CFO of Rhythm Pharmaceuticals, sold a portion of his common stock to cover withholding taxes related to vesting restricted stock units.
Summary
- On February 12, 2025, Hunter C. Smith, the Chief Financial Officer of Rhythm Pharmaceuticals, sold shares of common stock.
- A total of 751 shares were sold at prices of $56.39 and $56.22 per share.
- The sales were executed under a pre-existing Rule 10b5-1 trading plan adopted before February 27, 2023.
- The purpose of the sales was solely to cover withholding taxes associated with the vesting of previously reported restricted stock units.
- Following the transactions, Smith directly owns 105,544 shares of Rhythm Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The Form 4 filing represents a routine transaction (sale of shares to cover taxes) and does not inherently indicate positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| February 27, 2023 | Date before which the Rule 10b5-1 instruction was adopted. |
| February 12, 2025 | Date of the stock sale transaction. |
| February 14, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.